Form 8-K - Current report:
SEC Accession No. 0001193125-19-160233
Filing Date
2019-05-30
Accepted
2019-05-30 07:21:55
Documents
3
Period of Report
2019-05-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d747725d8k.htm 8-K 17630
2 EX-99.1 d747725dex991.htm EX-99.1 12803
3 GRAPHIC g747725g0530022239625.jpg GRAPHIC 3122
  Complete submission text file 0001193125-19-160233.txt   36082
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 19864570
SIC: 2834 Pharmaceutical Preparations